No abstract available
MeSH terms
-
Aged
-
Aminoglycosides / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / blood*
-
Biomarkers, Tumor / genetics
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Gemtuzumab
-
Humans
-
Idarubicin / administration & dosage
-
Immunotoxins / therapeutic use*
-
Leukemia, Monocytic, Acute / blood
-
Leukemia, Monocytic, Acute / drug therapy*
-
Leukemia, Monocytic, Acute / genetics
-
Male
-
Myeloid-Lymphoid Leukemia Protein / blood*
-
Myeloid-Lymphoid Leukemia Protein / genetics
-
Neoplasm, Residual / drug therapy
-
Oncogene Proteins, Fusion / blood*
-
Oncogene Proteins, Fusion / genetics
-
Remission Induction
Substances
-
Aminoglycosides
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Immunotoxins
-
MLL-AF9 fusion protein, human
-
Oncogene Proteins, Fusion
-
Cytarabine
-
Myeloid-Lymphoid Leukemia Protein
-
Gemtuzumab
-
Idarubicin
-
Daunorubicin